Senior Director, Oncology Marketing at Corcept Therapeutics

Redwood City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Oncology, BiotechnologyIndustries

Requirements

Proven ability to lead and develop high-performing marketing teams, fostering accountability, innovation, and professional growth
Demonstrated excellence in strategic planning, communication, and project execution within complex, fast-paced environments
Demonstrated strength collaborating cross-functionally across the organization
Extensive experience managing external agency partnerships and collaborating across functions
Deep oncology expertise
Strategic leadership
Proven ability to translate customer insights into actionable strategies in a fast-paced, growth stage environment

Responsibilities

Lead the US HCP and patient oncology marketing team in delivering a highly successful launch for relacorilant in ovarian cancer and future pipeline assets. Foster a high-performing, collaborative and innovative team culture
Provide global brand leadership, developing and executing data-driven, cross-functionally integrated marketing strategies that drive product adoption. Partner with Medical Affairs, Market Access, Business Analytics, and Sales to ensure strategic alignment and excellence in execution
Lead market development and disease education initiatives to raise awareness of the glucocorticoid receptor pathway in cancer and its potential as a novel therapeutic approach. Partner with Medical Affairs in building relationships with KOLs and patient advocacy groups
Lead marketing promotional activities. Ensure alignment of tactical plans with the brand strategy, budget, and business impact. Drive messaging consistency through the organization and across personal and non-personal channels. Collaborate with Sales leadership and Training to ensure effective field execution
Collaborate in the design and implementation of a robust omnichannel marketing strategy that delivers personalized, insight-driven customer experiences across platforms
Establish and manage key performance indicators (KPIs) that measure brand performance, ensuring accountability for achieving business objectives and continuous optimization
Manage agency partnerships, budgets, and workflow to ensure creative excellence, operational efficiency, and alignment with strategic business objectives
Ensure full compliance with regulatory, legal, and medical standards across all marketing materials, maintaining the highest level of scientific accuracy and ethical integrity
Champion Corcept’s key principles by fostering collaboration, embracing innovation, grounding decisions in data, and leading by example, ensuring all initiatives reflect the company’s ethics and unwavering commitment to patients

Skills

Oncology Marketing

Brand Strategy

HCP Marketing

Patient Marketing

Launch Execution

Strategic Leadership

Customer Insights

Cross-Functional Collaboration

Market Access

Business Analytics

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free